You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

melanoma

Showing 26 - 50 of 5,258
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Analysis of Circulating Exosomes in Melanoma Patients

Active, not recruiting
  • Melanoma
    • Besançon, France
      CHU de Besançon
    Feb 23, 2023

    Acral Melanoma Trial (camrelizumab+apatinib+TMZ, camrelizumab+apatinib, camrelizumab)

    Not yet recruiting
    • Acral Melanoma
    • (no location specified)
    Mar 16, 2023

    Blocking TNF to Potentiate ICI-dependent Immune Awakening in

    Recruiting
    • Melanoma
    • +2 more
      • Toulouse, France
        Institut Claudius Regaud
      May 25, 2023

      Advanced Melanoma Trial in Basel (Combination of Tumor-infiltrating lymphocyte transfer with ANV419)

      Not yet recruiting
      • Advanced Melanoma
      • Combination of Tumor-infiltrating lymphocyte transfer with ANV419
      • Basel, Switzerland
        University Hospital Basel
      May 19, 2023

      Melanoma Stage III Trial in Shanghai (Toripalimab combined with Temozolomide)

      Not yet recruiting
      • Melanoma Stage III
      • Toripalimab combined with Temozolomide
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Apr 23, 2023

      Melanoma (Skin) Trial (Sodium Chloride Granules, Water)

      Not yet recruiting
      • Melanoma (Skin)
      • Sodium Chloride Granules
      • Water
      • (no location specified)
      May 2, 2023

      Melanoma Stage III, In-Transit Metastasis of Cutaneous Melanoma Trial in Leiden (Encorafenib + Binimetinib)

      Recruiting
      • Melanoma Stage III
      • In-Transit Metastasis of Cutaneous Melanoma
      • Encorafenib + Binimetinib
      • Leiden, Zuid-Holland, Netherlands
        Leiden University Medical Center
      Mar 2, 2023

      Baseline Metastases on Clinical Outcomes Among BRAF Positive

      Completed
      • BRAF Positive Metastatic Melanoma
        • East Hanover, New Jersey
          Novartis
        Aug 2, 2023

        Healthcare Resource Utilization and Costs in Metastatic Melanoma

        Terminated
        • Metastatic Melanoma
          • East Hanover, New Jersey
            Novartis Investigational Site
          Apr 27, 2023

          Morphological, Genetic and Tumour Microenvironment

          Recruiting
          • Uveal Melanoma
          • cytogenetic analysis on tumour tissue
          • Digital Pathology
          • Rome, Italy
            Monica Maria Pagliara - Oncologia Oculare
          May 26, 2023

          Gut and Tumor Microbiome in Advanced ER-positive and

          Not yet recruiting
          • Breast Cancer
          • Melanoma
          • Observation
          • (no location specified)
          Nov 6, 2023

          Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Jacksonville (drug,

          Active, not recruiting
          • Metastatic Melanoma
          • +3 more
          • Jacksonville, Florida
            Mayo Clinic in Florida
          Jan 3, 2023

          Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

          Recruiting
          • Clinical Stage I Cutaneous Melanoma AJCC v8
          • +13 more
          • Houston, Texas
            M D Anderson Cancer Center
          Dec 16, 2022

          Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

          Recruiting
          • Metastatic Uveal Melanoma
          • Grand Rapids, Michigan
            The Cancer and Hematology Centers
          Aug 14, 2023

          Melanoma Trial in Scottsdale (Educational Intervention, Questionnaire Administration)

          Active, not recruiting
          • Melanoma
          • Educational Intervention
          • Questionnaire Administration
          • Scottsdale, Arizona
            Mayo Clinic in Arizona
          Jan 4, 2023

          Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV Trial in Iowa City, Rochester, Madison ([212Pb]VMT01)

          Not yet recruiting
          • Melanoma (Skin)
          • +5 more
          • Iowa City, Iowa
          • +2 more
          Dec 8, 2022

          Tumor Infiltrating Lymphocytes, Safety, Melanoma Trial in Beijing (GC101 TIL)

          Recruiting
          • Tumor Infiltrating Lymphocytes
          • +4 more
          • GC101 TIL
          • Beijing, China
            Beijing Cancer Hospital
          Nov 7, 2023

          Immunotherapy in Patients With Metastatic Melanoma

          Not yet recruiting
          • Metastatic Melanoma
          • data collection
          • (no location specified)
          Nov 28, 2022

          Metastatic Melanoma, Immune Checkpoints Inhibitors, Gastrointestinal Microbiome (Bacterial and Viral) Trial in Ljubljana (Immune

          Recruiting
          • Metastatic Melanoma
          • +3 more
          • Immune checkpoint inhibitor
          • Ljubljana, Slovenia
            Institute of Oncology Ljubljana
          May 17, 2023

          Generation ofArtificial Intelligence Algorithm Based on Analysis

          Not yet recruiting
          • Metastatic Melanoma
          • Photo
          • (no location specified)
          May 3, 2023

          Melanoma, Metastatic Melanoma Trial in Boston (CDX-301, NEOVAX, Nivolumab)

          Recruiting
          • Melanoma
          • Metastatic Melanoma
          • Boston, Massachusetts
            Dana-Farber Cancer Institute
          Jan 12, 2023

          Melanoma Trial (V940, Pembrolizumab, Placebo)

          Not yet recruiting
          • Melanoma
          • V940
          • +2 more
          • (no location specified)
          Jul 12, 2023

          Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,

          Recruiting
          • Clinical Stage III Cutaneous Melanoma AJCC v8
          • Clinical Stage IV Cutaneous Melanoma AJCC v8
          • Shanghai, China
            Fudan University Shanghai Cancer Center
          Jun 17, 2023

          Melanoma Trial in Philadelphia (Mature dendritic cell (DC) vaccine, Cyclophosphamide 300mg/m^2, Pembrolizumab)

          Active, not recruiting
          • Melanoma
          • Mature dendritic cell (DC) vaccine
          • +2 more
          • Philadelphia, Pennsylvania
            University of Pennsylvania
          Feb 2, 2023

          Metastatic Melanoma, Unresectable Melanoma, Melanoma Trial (Lifileucel plus Pembrolizumab, Pembrolizumab with Optional Crossover

          Not yet recruiting
          • Metastatic Melanoma
          • +2 more
          • Lifileucel plus Pembrolizumab
          • Pembrolizumab with Optional Crossover Period
          • (no location specified)
          Feb 13, 2023